<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tumor microenvironment inflammation &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tumor-microenvironment-inflammation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:58:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Tumor microenvironment inflammation &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ADAMTS2 Drives EMT and Inflammation in Ovarian Cancer</title>
		<link>https://bioengineer.org/adamts2-drives-emt-and-inflammation-in-ovarian-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 26 Aug 2025 12:13:27 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[ADAMTS2 gene]]></category>
		<category><![CDATA[Bioinformatic cancer biomarkers]]></category>
		<category><![CDATA[Epithelial-mesenchymal transition (EMT)]]></category>
		<category><![CDATA[High-grade serous ovarian cancer]]></category>
		<category><![CDATA[Tumor microenvironment inflammation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/adamts2-drives-emt-and-inflammation-in-ovarian-cancer/</guid>

					<description><![CDATA[In a groundbreaking new study published in BMC Cancer, researchers have unveiled a pivotal role for the gene ADAMTS2 in driving epithelial–mesenchymal transition (EMT) and inflammatory processes within high-grade serous ovarian cancer (HGSOC). This research combines comprehensive bioinformatic analyses with robust experimental validation, shedding light on molecular mechanisms that until now remained dense mysteries in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">257979</post-id>	</item>
		<item>
		<title>Ephrin B3 Fuels Tumor Growth and Inflammation</title>
		<link>https://bioengineer.org/ephrin-b3-fuels-tumor-growth-and-inflammation/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 04 Aug 2025 21:26:12 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer therapeutic targets]]></category>
		<category><![CDATA[cutaneous squamous cell carcinoma]]></category>
		<category><![CDATA[Ephrin B3 in cancer]]></category>
		<category><![CDATA[Ephrin-Eph signaling pathways]]></category>
		<category><![CDATA[Tumor microenvironment inflammation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ephrin-b3-fuels-tumor-growth-and-inflammation/</guid>

					<description><![CDATA[In a groundbreaking study published recently in Medical Oncology, scientists have uncovered the pivotal role of Ephrin B3, a member of the Ephrin protein family, in orchestrating the aggressive progression of cutaneous squamous cell carcinoma (cSCC). This malignancy, which originates from the squamous cells in the epidermis, is notorious for its ability to invade locally [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">253059</post-id>	</item>
	</channel>
</rss>
